An interventional study of musicotherapy in Stress Disorder, Post Traumatic, sponsored by Institut de Recherche Biomedicale des Armees. Terminated at 1 site in France. Per ClinicalTrials.gov, last updated 2022-08-04.
Sponsored by Institut de Recherche Biomedicale des Armees · Not applicable, Interventional, and Supportive care
PTSD is a debilitating mental disorder that may develop after experiencing or witnessing a life-threatening event. With appropriate care, treatment efficiency is variable and around 20% of the patients do not respond to psychological treatment. Complementary treatments are needed.
as PTSD implied autonomic nervous system (ANS) dysfonction, complementary treatment focusing on ANS regulation, as welle as musicotherapy, may have an interest.
The aim is to evaluate the impact of musicotherapy on PTSD symptoms, and severity using a RCT Symptoms will be evaluated using questionaires (PCL and quality of life) severity will be measured using neurological soft signs assessment, connectomic functions and ANS regulation
2,284 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 557 are open to participants now.
This study's enrollment of 15 is below the median of 70 across 1,897 interventional studies indexed under Stress Disorders, Post-Traumatic.
Browse Stress Disorders, Post-Traumatic studies →Institut de Recherche Biomedicale des Armees is the lead sponsor of 12 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
daily sessions of music listening during 2 months, associated with their standard treatment,
Other: musicotherapy
waiting list
receptive music therapy. The musical style of the session was chosen by the patient. The validated 'U' technique was employed.
change in PTSD symptoms
questionnaire Posttraumatic CheckList 5 (PCL5; threshold =33)
Time frame: change from PTSD symptoms at two months and at six months
change in neurological soft signs
questionnaire EPSID " Psychomotor assessment scale of neurological soft signs no threshold
Time frame: change from neurological soft signs at two months and at six months
change in effective connectomic
Magnetic Resonance Imaging
Time frame: change from effective connectomic at two months and at six months
Autonomous nervous system regulation
heart rate variability during 5 min at rest
Time frame: change from Autonomous nervous system regulation at two months and at six months
change in biological stress
blood cytokines, BDNF
Time frame: change from biological stress at two months and at six months
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stress Disorders, Post-Traumatic →
Institut de Recherche Biomedicale des Armees